Byetta Heart Risk Information Concealed from FDA: Memo

Administrator 50 AboutLawsuits.com
Print Email

Recently revealed government records suggest that Amylin Pharmaceuticals may have attempted to hide information about the potential risk of heart problems from Byetta, which was a factor in the FDA’s delayed approval for a new long-lasting version of the diabetes drug that is marketed under the brand name Bydureon. Byetta (exenatide) was originally introduced in [...]
Read Full Article


x

You can contact us at:
info@realtruthtalks.com